First FDA-approved CAR-T Cell Therapy for Lymphoma to Be Available at City of Hope

October 18, 2017 | City of Hope

City of Hope will be the one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. FDA announced today is the first approved CAR-T therapy for adult patients for some types of non-Hodgkin lymphoma

Continue Reading

TGen Spotlight: New Study Tackles Sports-Related Concussions

October 16, 2017 | City of Hope

TGen-Riddell partnership results could help future studies lead to advanced methods of injury and disease detection

Leukemia and Autoimmune Disease Targeted in City of Hope-Caltech Collaboration

October 10, 2017 | Wayne Lewis

The Caltech-City of Hope Biomedical Research Initiative combines the strengths of these top Southern California research institutions to accelerate scientific investigations and fight disease.

Behnam Badie given $2.1 million R01 grant to study RAGE

May 3, 2017 | Denise Heady

What started as an unplanned lunch date has turned into a potential breakthrough in the treatment of gliomas – a fast-growing, and often deadly type of brain tumor.

City of Hope Partners with Scripps to Find New Treatment for HIV

May 2, 2017 | Michael Easterling

A team from The Scripps Research Institute (TSRI) in La Jolla, California, is working with City of Hope’s Center for Gene Therapy to test a cell culture resistant to the HIV virus for efficacy and safety. If testing goes as planned, TSRI and City of Hope investigators may have identified a new treatment for HIV.

TGen Identifies Promising New Compound for Treatment of Glioblastoma

April 20, 2017 | City of Hope

A study led by scientists at the Translational Genomics Research Institute (TGen) has identified a chemical compound called Aurintricarboxylic Acid (ATA), shown to block the chemical cascade that otherwise allows glioblastoma cells to resist both chemo and radiation therapy.

Experts Discuss Advancements in Stem Cell Therapies at Second Annual Meeting

March 29, 2017 | Michael Easterling

The stories of patients who have benefited from stem cell therapies funded by the California Institute for Regenerative Medicine (CIRM) were the focus of the second symposium of the institute’s Alpha Stem Cell Clinics Network.

City of Hope and TGen Join Forces to Advance Precision Medicine

December 2, 2016 | City of Hope

City of Hope is joining forces with the Translational Genomics Research Institute (TGen) to accelerate the speed with which scientists and medical staff can convert research discoveries into cures for patients.

Collaboration leads to new pathway to increase drug sensitivity

October 19, 2016 | Katie Neith

Science doesn’t always start in the lab. Sometimes collaborations come together over cocktails in Costa Rica. This is how City of Hope cancer biologist Mei Kong Ph.D., and Caltech neuroscientist Viviana Gradinaru, Ph.D., started a project that could change the approach to killing cancerous tumors.